Author

P. Crews

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:C. elegans· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Alcala· 1 shared A. Hruby· 1 shared A. J. Smith· 1 shared C. Lagisetti· 1 shared G. Garcia· 1 shared H. H. Mehta· 1 shared H. Shaghasi· 1 shared J. A. Gerke· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Alcala

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Investigating impacts of marine sponge derived mycothiazole and its acetylated derivative on mitochondrial function and aging.

N. Dutta, J. A. Gerke, S. F. Ordon, J. D. Morris, A. Hruby, T. C. Torres, S. Shemtov, J. G. Clark, M. C. Chang, H. Shaghasi, M. N. Ray, M. Averbukh, S. Hoang, M. Oorloff, A. Alcala, , R. Higuchi-Sanabria

This study investigates the effects of marine sponge-derived mycothiazole and its acetylated derivative on mitochondrial function and aging using in vitro and in vivo models.

bioRxiv · Nov 27, 2023Cell Biology

An Exon Skipping Screen Identifies Antitumor Drugs That Are Potent Modulators of Pre-mRNA Splicing, Suggesting New Therapeutic Applications

Y. Shi, W. Bray, A. J. Smith, W. Zhou, J. Calaoagan, C. Lagisetti, L. Sambucetti, P. Crews, R. S. Lokey, T. R. Webb

The paper identifies antitumor drugs that modulate pre-mRNA splicing through a screening assay, revealing new therapeutic applications and SF3B1 antagonists.

bioRxiv · Mar 21, 2019Cancer Biology